Hennion & Walsh Asset Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,891
| Closed | -$259K | – | 921 |
|
|
2025
Q1 | $259K | Sell |
1,891
-192
| -9% | -$26.3K | 0.01% | 786 |
|
|
2024
Q4 | $319K | Sell |
2,083
-3,430
| -62% | -$525K | 0.01% | 741 |
|
|
2024
Q3 | $1.07M | Sell |
5,513
-1,277
| -19% | -$248K | 0.05% | 439 |
|
|
2024
Q2 | $1.57M | Sell |
6,790
-184
| -3% | -$42.7K | 0.08% | 310 |
|
|
2024
Q1 | $1.5M | Sell |
6,974
-93
| -1% | -$20.1K | 0.08% | 317 |
|
|
2023
Q4 | $1.83M | Buy |
7,067
+319
| +5% | +$82.5K | 0.1% | 260 |
|
|
2023
Q3 | $1.73M | Buy |
6,748
+1,573
| +30% | +$404K | 0.11% | 237 |
|
|
2023
Q2 | $1.47M | Buy |
5,175
+2,709
| +110% | +$772K | 0.09% | 283 |
|
|
2023
Q1 | $686K | Buy |
2,466
+376
| +18% | +$105K | 0.04% | 436 |
|
|
2022
Q4 | $579K | Buy |
+2,090
| New | +$579K | 0.04% | 467 |
|
|
2022
Q2 | – | Sell |
-1,095
| Closed | -$231K | – | 761 |
|
|
2022
Q1 | $231K | Sell |
1,095
-563
| -34% | -$119K | 0.01% | 711 |
|
|
2021
Q4 | $398K | Sell |
1,658
-462
| -22% | -$111K | 0.02% | 591 |
|
|
2021
Q3 | $600K | Buy |
2,120
+103
| +5% | +$29.2K | 0.03% | 467 |
|
|
2021
Q2 | $698K | Sell |
2,017
-338
| -14% | -$117K | 0.04% | 443 |
|
|
2021
Q1 | $659K | Buy |
+2,355
| New | +$659K | 0.04% | 449 |
|